About Acute Myelogenous Leukemia
(AML) Acute myelogenous leukemia
(AML) is a rapidly progressing cancer of the blood and bone marrow and is one of the most common types of leukemia among adults.
Table 54: Leukemia Market to 2018, Acute Myelogenous Leukemia
, Global, Revenue Forecasts ($m), 2011-2018 72
Acute myelogenous leukemia
develops when there's a defect in the immature cells in the bone marrow.
The incidence rate of acute myelogenous leukemias
(AMLs) in the United States is approximately 2.
The database currently tags 14,000 individuals working in Acute Myelogenous Leukemia
These abstracts include summaries of data from studies in acute myelogenous leukemia
, myelodysplastic syndrome (MDS) and acute lymphocytic leukemia (ALL).
Acute myelogenous leukemia
(AML), Acute promyelocytic leukemia (APL), Acute leukemias, Consolidation therapy, Induction therapy, Bone marrow transplantation (BMT), Chemotherapy, Amonafide malate, Clolar (clofarabine), Dacogen (decitabine), Midostaurin, Onrigin (laromustine), Blood cancers
Food and Drug Administration (FDA) has designated the Companies' histone deacetylase (HDAC) inhibitor, MGCD0103, as an Orphan Drug for the treatment of acute myelogenous leukemia
(AML) in the United States.
Phillip Neiens has acute myelogenous leukemia
, the most common leukemia in adults with some 10,000 new cases annually.
Anderson team focused on 43 men and women with acute myelogenous leukemia
(AML), a particularly severe form of leukemia.
PK), a developer of transrenal molecular diagnostics, announced today that LabCorp, one of the world's leading reference laboratories, (LabCorp, NYSE:LH), and InVivoScribe Technologies, a world leader in molecular hematopathology testing, have notified the Company that they have begun laboratory testing services for the detection of NPM1 mutations for the diagnosis of acute myelogenous leukemia
TSX: MYG) today announced that the European Medicines Agency (EMEA) and the European Commission (EC) designated MGCD0103, a histone deacetylase (HDAC) inhibitor, as an Orphan Medicinal Product for the treatment of acute myelogenous leukemia
in the European Union (EU).
Meghan Torp received a cup of 4-year-old Zachary's born marrow to help rebuild her blood cells that have been plagued with acute myelogenous leukemia
, an extremely aggressive cancer.
com/research/f4ffea/acute_lymphoblasti) has announced the addition of the "Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia
or Hairy Cell Leukemia Therapy Area Pipeline Report" report to their offering.
today announced that it will proceed to the second stage of accrual to its pivotal Phase II trial of Cloretazine(R) (VNP40101M) in previously untreated elderly patients with de novo poor-risk acute myelogenous leukemia